Arcus Biosciences (RCUS) Set to Join S&P SmallCap 600

Arcus Biosciences Inc. (NYSE: RCUS) will replace Investors Bancorp Inc. (NASD:ISBC) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, April 7. S&P 500 constituent Citizens Financial Group Inc. (NYSE: CFG) is acquiring Investors Bancorp in a deal expected to be completed soon pending final closing conditions.

You May Also Be Interested In

• Spotify (SPOT) jumps 10% as Q1 revenue, gross margins beat Street's estimates
• Whirlpool (WHR) Appoints Roxanne Warner as Corporate Controller
• PaxMedica (PXMD) Responds to Emergency Request for IV Suramin, Commits to Provide Immediate Access to PAX-101